BioAge raises $170M as obesity spotlight shifts to oral options, muscle preservers

in Portfolio News

BioAge Labs has reeled in the biotech industry’s largest private financing round so far in 2024 as the California startup goes full throttle on the hottest areas in obesity drug development: oral formulations and muscle preservation.


View the article
Investing in Women Code Logo
PROUD SIGNATORIES

We invest in talented innovators. We strongly adhere to the view that diversity, including under-represented groups, strongly adds to success. If you are an entrepreneur seeking investment and a partner who can help you to build your business, we would love to hear from you. Please get in contact with our team.